Almost 90% of drug candidates fail in clinical trials, and nearly half of those failures occur to blind spots around Absorption, Distribution, Metabolism, Excretion, and Toxicity properties. An AI-powered solution from Edmonton’s Proholistic Discovery aims to empower researchers to make data-informed decisions earlier in the process. “With deep expertise spanning target identification, lead optimization, and […]
Calgary.Tech